会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • MUFFLER
    • 围巾
    • US20090229912A1
    • 2009-09-17
    • US12227117
    • 2007-05-16
    • Takeshi HaraHideyuki KomitsuMasayuki Sudo
    • Takeshi HaraHideyuki KomitsuMasayuki Sudo
    • F01N1/00
    • F01N1/166F01N1/084F01N1/089F01N2490/06
    • A muffler has a casing with a plurality of sound-muffling chambers, exhaust pipes that pass through at least two sound-muffling chambers and to pass through exhaust from an engine, a plurality of apertures provided in each exhaust pipe, and a plurality of valves provided in each of the apertures. In this muffler, the plurality of apertures are provided at the locations at which an exhaust flow from one aperture and an exhaust flow from another aperture do not interfere with each other. When there are two apertures, the apertures are provided at positions in the exhaust pipes at which the apertures do not face each other. For this reason, by avoiding interference between exhaust flows from the two apertures, it is possible to suppress an abnormal sound caused by the interference.
    • 消声器具有壳体,该壳体具有多个声音消音室,排气管通过至少两个声音消声室并且通过来自发动机的排气,设置在每个排气管中的多个孔,以及多个阀 设置在每个孔中。 在这种消音器中,多个孔设置在来自一个孔的排出流和来自另一个孔的排出流不彼此干涉的位置处。 当存在两个孔时,孔被设置在排气管中的孔不彼此面对的位置处。 为此,通过避免来自两个孔的排出流之间的干扰,可以抑制由干涉引起的异常声音。
    • 7. 发明授权
    • Biomarker for diagnosis of liver disease
    • 用于肝脏疾病诊断的生物标志物
    • US08263347B2
    • 2012-09-11
    • US12738684
    • 2008-10-20
    • Hirohito TsubouchiHirofumi UtoTakeshi OkanoueYo-ichi IshidaYuko SatoMasayuki Sudo
    • Hirohito TsubouchiHirofumi UtoTakeshi OkanoueYo-ichi IshidaYuko SatoMasayuki Sudo
    • G01N33/53
    • G01N33/6893G01N2333/8139G01N2800/085
    • Disclosed are: a marker for the diagnosis of a liver disease, which can determine the disease in a simple manner; an antibody directed against the marker; a diagnostic agent; a diagnosis method; and a method for marker detection in blood or serum. Proteome analysis revealed that quantities of the full-length kininogen and three partial peptides thereof (sequence A: position-440 to position-456, sequence B: position-439 to position-456, and sequence C: position-438 to position-456) in sera of patients with non-alcoholic fatty liver disease are significantly different from those in sera of healthy individuals; and a diagnostic agent and a detecting method for the non-alcoholic fatty liver disease that can be conveniently used for medical examination are established. The use of a combination of a kininogen-based marker and a C4-based marker (the full length sequence or partial peptides thereof) enables identification of chronic hepatitis and an asymptomatic virus carrier, as well as non-alcoholic fatty liver disease.
    • 公开了一种用于诊断肝脏疾病的标志物,其可以以简单的方式确定疾病; 针对标记的抗体; 诊断剂; 诊断方法; 以及血液或血清中标记物检测的方法。 蛋白质组分析显示,全长激肽原及其三个部分肽(序列A:位置440至位置-456,序列B:位置-439至位置-456,序列C:位置-438至位置-456) )与非酒精性脂肪性肝病患者的血清显着不同于健康人血清; 并建立了可以方便地用于体格检查的非酒精性脂肪肝疾病的诊断剂和检测方法。 使用基于激肽原的标记物和基于C4的标记物(其全长序列或其部分肽)的组合能够鉴定慢性肝炎和无症状病毒载体以及非酒精性脂肪肝疾病。
    • 8. 发明申请
    • BIOMARKER FOR DIAGNOSIS OF LIVER DISEASE
    • 生物标志物诊断肝病
    • US20110129859A1
    • 2011-06-02
    • US12738684
    • 2008-10-20
    • Hirohito TsubouchiHirofumi UtoTakeshi OkanoueYo-ichi IshidaYuko SatoMasayuki Sudo
    • Hirohito TsubouchiHirofumi UtoTakeshi OkanoueYo-ichi IshidaYuko SatoMasayuki Sudo
    • G01N33/53C07K7/08C07K14/435C07K16/18
    • G01N33/6893G01N2333/8139G01N2800/085
    • Disclosed are: a marker for the diagnosis of a liver disease, which can determine the disease in a simple manner; an antibody directed against the marker; a diagnostic agent; a diagnosis method; and a method for marker detection in blood or serum. Proteome analysis revealed that quantities of the full-length kininogen and three partial peptides thereof (sequence A: position-440 to position-456, sequence B: position-439 to position-456, and sequence C: position-438 to position-456) in sera of patients with non-alcoholic fatty liver disease are significantly different from those in sera of healthy individuals; and a diagnostic agent and a detecting method for the non-alcoholic fatty liver disease that can be conveniently used for medical examination are established. The use of a combination of a kininogen-based marker and a C4-based marker (the full length sequence or partial peptides thereof) enables identification of chronic hepatitis and an asymptomatic virus carrier, as well as non-alcoholic fatty liver disease.
    • 公开了:用于诊断肝脏疾病的标志物,其可以以简单的方式确定疾病; 针对标记的抗体; 诊断剂; 诊断方法; 以及血液或血清中标记物检测的方法。 蛋白质组分析显示,全长激肽原及其三个部分肽(序列A:位置440至位置-456,序列B:位置-439至位置-456,序列C:位置-438至位置-456) )与非酒精性脂肪性肝病患者的血清显着不同于健康人血清; 建立了可以方便地用于体格检查的非酒精性脂肪肝疾病的诊断剂和检测方法。 使用基于激肽原的标记物和基于C4的标记物(其全长序列或其部分肽)的组合能够鉴定慢性肝炎和无症状病毒载体以及非酒精性脂肪肝疾病。
    • 9. 发明授权
    • Muffler
    • 围巾
    • US07753168B2
    • 2010-07-13
    • US12227117
    • 2007-05-16
    • Takeshi HaraHideyuki KomitsuMasayuki Sudo
    • Takeshi HaraHideyuki KomitsuMasayuki Sudo
    • F01N1/00F01N1/08F01N1/16
    • F01N1/166F01N1/084F01N1/089F01N2490/06
    • A muffler has a casing with a plurality of sound-muffling chambers, exhaust pipes that pass through at least two sound-muffling chambers and to pass through exhaust from an engine, a plurality of apertures provided in each exhaust pipe, and a plurality of valves provided in each of the apertures. In this muffler, the plurality of apertures are provided at the locations at which an exhaust flow from one aperture and an exhaust flow from another aperture do not interfere with each other. When there are two apertures, the apertures are provided at positions in the exhaust pipes at which the apertures do not face each other. For this reason, by avoiding interference between exhaust flows from the two apertures, it is possible to suppress an abnormal sound caused by the interference.
    • 消声器具有壳体,该壳体具有多个声音消音室,排气管通过至少两个声音消声室并且通过来自发动机的排气,设置在每个排气管中的多个孔,以及多个阀 设置在每个孔中。 在这种消音器中,多个孔设置在来自一个孔的排出流和来自另一个孔的排出流不彼此干涉的位置处。 当存在两个孔时,孔被设置在排气管中的孔不彼此面对的位置处。 为此,通过避免来自两个孔的排出流之间的干扰,可以抑制由干涉引起的异常声音。